Sudarshan Pharma announces 1:10 stock split after 400% share price surge this year

Sudarshan Pharma Industries Ltd has announced a 1:10 stock split following a 412% increase in its share price this year. The stock opened at ₹427.45 on the BSE, slightly above its previous close. The company received shareholder approval for the stock split and submitted the results of remote e-voting for the resolution. The voting concluded on November 3, 2024. In recent developments, Sudarshan Pharma established a subsidiary focused on pharmaceuticals and acquired Ratna Lifesciences Pvt Ltd to enter the oncology market. The company is also expanding its plant capacity in Maharashtra.